Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum

por Gershenson, David M., Bhosale, Priya, Grisham, Rachel N.
Publicado 2020

Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience

por Rubinstein, Maria, Halpenny, Darragh, Makker, Vicky, Grisham, Rachel N., Aghajanian, Carol, Cadoo, Karen
Publicado 2019

Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation()

por Martin, Madhuri, Grisham, Rachel N., Turashvili, Gulisa, Halpenny, Darragh F., Aghajanian, Carol A., Makker, Vicky
Publicado 2017

Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models

por Wise, Hannah C., Iyer, Gopakumar V., Moore, Kathleen, Temkin, Sarah M., Gordon, Sarah, Aghajanian, Carol, Grisham, Rachel N.
Publicado 2019

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

por Gordhandas, Sushmita B., Manning-Geist, Beryl, Henson, Christina, Iyer, Gopa, Gardner, Ginger J., Sonoda, Yukio, Moore, Kathleen N., Aghajanian, Carol, Chui, M. Herman, Grisham, Rachel N.
Publicado 2022

Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study

por Colombo, Nicoletta, Van Gorp, Toon, Matulonis, Ursula A., Oaknin, Ana, Grisham, Rachel N., Fleming, Gini F., Olawaiye, Alexander B., Nguyen, Dorothy D., Greenstein, Andrew E., Custodio, Joseph M., Pashova, Hristina I., Tudor, Iulia C., Lorusso, Domenica
Publicado 2023

Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma

por Veeraraghavan, Harini, Vargas, Herbert Alberto, Jimenez-Sanchez, Alejandro, Micco, Maura, Mema, Eralda, Lakhman, Yulia, Crispin-Ortuzar, Mireia, Huang, Erich P., Levine, Douglas A., Grisham, Rachel N., Abu-Rustum, Nadeem, Deasy, Joseph O., Snyder, Alexandra, Miller, Martin L., Brenton, James D., Sala, Evis
Publicado 2020

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade

por Boland, Julia L., Zhou, Qin, Martin, Madhuri, Callahan, Margaret K., Konner, Jason, O’Cearbhaill, Roisin E., Friedman, Claire F., Tew, William, Makker, Vicky, Grisham, Rachel N., Hensley, Martee L., Zecca, Nicholas, Iasonos, Alexia E., Snyder, Alexandra, Hyman, David M., Sabbatini, Paul, Aghajanian, Carol, Cadoo, Karen A., Zamarin, Dmitriy
Publicado 2018

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial

por Zamarin, Dmitriy, Walderich, Sven, Holland, Aliya, Zhou, Qin, Iasonos, Alexia E, Torrisi, Jean M, Merghoub, Taha, Chesebrough, Lewis F, Mcdonnell, Autumn S, Gallagher, Jacqueline M, Li, Yanyun, Hollmann, Travis J, Grisham, Rachel N, Erskine, Courtney L, Block, Mathew S, Knutson, Keith L, O’Cearbhaill, Roisin E, Aghajanian, Carol, Konner, Jason A
Publicado 2020

Low-grade serous ovarian cancer: expert consensus report on the state of the science

por Grisham, Rachel N, Slomovitz, Brian M, Andrews, Nicole, Banerjee, Susana, Brown, Jubilee, Carey, Mark S, Chui, Herman, Coleman, Robert L, Fader, Amanda N, Gaillard, Stephanie, Gourley, Charlie, Sood, Anil K, Monk, Bradley J, Moore, Kathleen N, Ray-Coquard, Isabelle, Shih, Ie-Ming, Westin, Shannon N, Wong, Kwong-Kwok, Gershenson, David M
Publicado 2023

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ov...

por Grisham, Rachel N., Vergote, Ignace, Banerjee, Susana, Drill, Esther, Kalbacher, Elsa, Mirza, Mansoor Raza, Romero, Ignacio, Vuylsteke, Peter, Coleman, Robert L., Hilpert, Felix, Oza, Amit M., Westermann, Anneke, Oehler, Martin K., Pignata, Sandro, Aghajanian, Carol, Colombo, Nicoletta, Cibula, David, Moore, Kathleen N., del Campo, Josep M., Berger, Regina, Marth, Christian, Sehouli, Jalid, O'Malley, David M., Churruca, Cristina, Kristensen, Gunnar, Clamp, Andrew, Farley, John, Iyer, Gopa, Ray-Coquard, Isabelle, Monk, Bradley J.
Publicado 2023

MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

por Monk, Bradley J., Grisham, Rachel N., Banerjee, Susana, Kalbacher, Elsa, Mirza, Mansoor Raza, Romero, Ignacio, Vuylsteke, Peter, Coleman, Robert L., Hilpert, Felix, Oza, Amit M., Westermann, Anneke, Oehler, Martin K., Pignata, Sandro, Aghajanian, Carol, Colombo, Nicoletta, Drill, Esther, Cibula, David, Moore, Kathleen N., Christy-Bittel, Janna, del Campo, Josep M., Berger, Regina, Marth, Christian, Sehouli, Jalid, O’Malley, David M., Churruca, Cristina, Boyd, Adam P., Kristensen, Gunnar, Clamp, Andrew, Ray-Coquard, Isabelle, Vergote, Ignace
Publicado 2020

Ovarian cancer mutational processes drive site-specific immune evasion

por Vázquez-García, Ignacio, Uhlitz, Florian, Ceglia, Nicholas, Lim, Jamie L. P., Wu, Michelle, Mohibullah, Neeman, Niyazov, Juliana, Ruiz, Arvin Eric B., Boehm, Kevin M., Bojilova, Viktoria, Fong, Christopher J., Funnell, Tyler, Grewal, Diljot, Havasov, Eliyahu, Leung, Samantha, Pasha, Arfath, Patel, Druv M., Pourmaleki, Maryam, Rusk, Nicole, Shi, Hongyu, Vanguri, Rami, Williams, Marc J., Zhang, Allen W., Broach, Vance, Chi, Dennis S., Da Cruz Paula, Arnaud, Gardner, Ginger J., Kim, Sarah H., Lennon, Matthew, Long Roche, Kara, Sonoda, Yukio, Zivanovic, Oliver, Kundra, Ritika, Viale, Agnes, Derakhshan, Fatemeh N., Geneslaw, Luke, Issa Bhaloo, Shirin, Maroldi, Ana, Nunez, Rahelly, Pareja, Fresia, Stylianou, Anthe, Vahdatinia, Mahsa, Bykov, Yonina, Grisham, Rachel N., Liu, Ying L., Lakhman, Yulia, Nikolovski, Ines, Kelly, Daniel, Gao, Jianjiong, Schietinger, Andrea, Hollmann, Travis J., Bakhoum, Samuel F., Soslow, Robert A., Ellenson, Lora H., Abu-Rustum, Nadeem R., Aghajanian, Carol, Friedman, Claire F., McPherson, Andrew, Weigelt, Britta, Zamarin, Dmitriy, Shah, Sohrab P.
Publicado 2022